Back to Search
GOLDA HUDES, MD
MD
Allergy & Immunology Physician
NPI: 1225119647Individual
Specialties, Licenses & Credentials
Allergy & Immunology PhysicianPrimary
Allergy & Immunology
Code: 207K00000X
204068(NY)
CMS Specialties
PrimaryALLERGY/IMMUNOLOGY
Education
OTHER
Class of 1979
Research & Publications (20)
Effect of temsirolimus versus interferon-alpha on outcome of patients with advanced renal cell carcinoma of different tumor histologies.
PMID 19229667·Med Oncol·2009
3-trial
NCCN clinical practice guidelines in oncology: kidney cancer.
PMID 19555584·J Natl Compr Canc Netw·2009
6-review
Phase I trial of sunitinib malate plus interferon-alpha for patients with metastatic renal cell carcinoma.
PMID 19213665·Clin Genitourin Cancer·2009
3-trial
NCCN clinical practice guidelines in oncology: testicular cancer.
PMID 19555582·J Natl Compr Canc Netw·2009
6-review
Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
PMID 19652060·J Clin Oncol·2009
3-trial
Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
PMID 19402064·Cancer·2009
8-other
The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria.
PMID 19558005·Ann Allergy Asthma Immunol·2009
4-observational
Analysis of PTEN and HIF-1alpha and correlation with efficacy in patients with advanced renal cell carcinoma treated with temsirolimus versus interferon-alpha.
PMID 19526589·Cancer·2009
3-trial
Role of androgen deprivation therapy for node-positive prostate cancer.
PMID 19047295·J Clin Oncol·2009
8-other
Functional antibody deficiency in a patient with type I Gaucher disease.
PMID 18392747·J Inherit Metab Dis·2008
5-case
NCCN Task Force Report: mTOR inhibition in solid tumors.
PMID 18926092·J Natl Compr Canc Netw·2008
6-review
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents.
PMID 18323557·J Clin Oncol·2008
8-other
Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel.
PMID 17618407·Invest New Drugs·2007
3-trial
Phase I/II trial of temsirolimus combined with interferon alfa for advanced renal cell carcinoma.
PMID 17761980·J Clin Oncol·2007
3-trial
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data.
PMID 17942366·Lancet Oncol·2007
1-meta
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.
PMID 17959415·Lancet Oncol·2007
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- MONTEFIORE MEDICAL PARK, 1515 BLONDELL AVENUE, STE. 220
BRONX, NY 10461 - Phone
- (866) 633-8255
Quick Facts
- NPI
- 1225119647
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 47
- Publications
- 20
Are you this provider?
Claim Your Profile